Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate

• Status: Completed
• Trial end date: 2013-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators hypothesize that fenofibrate/omega will improve insulin resistance compared with fenofibrate

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Gachon University Gil Medical Center
• Treatments: Fenofibrate

Criteria

Inclusion Criteria:

• hypertriglyceridemia

Exclusion Criteria:

• moderate or severe hypertension, uncontrolled diabetes (HbA1c > 9%), nephrotic syndrome, hypothyroidism, coronary artery disease, or peripheral vascular disease